Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Biotechnology Fund

+ Add to Watchlist

RYBOX:US

90.93 USD 0.15 0.17%

As of 09:29:30 ET on 04/20/2015.

Snapshot for Rydex Series - Biotechnology Fund (RYBOX)

Year To Date: +18.14% 3-Month: +10.94% 3-Year: +40.08% 52-Week Range: 56.10 - 93.57
1-Month: -2.33% 1-Year: +60.24% 5-Year: +29.38% Beta vs SPX: 1.00

Mutual Fund Chart for RYBOX

No chart data available.
  • RYBOX:US 90.93
  • 1M
  • 1Y
Interactive RYBOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYBOX

Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.

Inception Date: 09-01-2004 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / RYAN HARDER
Web Site: www.guggenheiminvestments.com

Fundamentals for RYBOX

NAV (on 2015-04-20) 90.93
Assets (M) (on 2015-04-20) 732.67
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYBOX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-11-18) 2.57
Dividend Yield (ttm) 3.47

Fees & Expenses for RYBOX

Front Load 4.75
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.61

Top Fund Holdings for RYBOX

Filing Date: 03/31/2015
Name Position Value % of Total
Gilead Sciences Inc 477,742 46,880,822 6.681%
Amgen Inc 263,144 42,063,568 5.995%
Biogen Inc 93,401 39,437,638 5.621%
Celgene Corp 319,185 36,795,647 5.244%
Regeneron Pharmaceuticals Inc 54,314 24,521,685 3.495%
Alexion Pharmaceuticals Inc 132,602 22,979,927 3.275%
Vertex Pharmaceuticals Inc 168,670 19,898,000 2.836%
Illumina Inc 105,123 19,515,034 2.781%
BioMarin Pharmaceutical Inc 142,144 17,713,985 2.525%
Pharmacyclics Inc 67,200 17,199,840 2.451%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil